金达威(002626) - 2015年12月10日投资者关系活动记录表

Group 1: Strategic Transformation - The company is accelerating its strategic transformation towards globalization and product specialization, evidenced by recent acquisitions in the dietary supplement sector [1] - The acquisition of Doctor's Best Holdings, Inc. marks a successful expansion from raw material supply to end-product sales [2] - The recent acquisition of Vitatech Nutrition Sciences, Inc. enhances the company's health product production line, completing its supply chain from raw materials to sales [2] Group 2: Sales Plans and Channels - Doctor's Best brand products are primarily sold through cross-border e-commerce platforms and a flagship store on JD.com, aiming to enhance brand influence in both domestic and international markets [2] - The sales channels for the company's Coenzyme Q10 product include its official mall, JD.com, and various pharmacies, with ongoing efforts to diversify sales channels [3] Group 3: Future Development and Profitability - The company plans to utilize existing production capacity from VitaBest to reduce production costs and increase revenue through synergy effects [3] - The decline in profits for 2015 is attributed to the continued low prices of Vitamin A products and increased costs from new product promotions [4]